Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 18,880 NVAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| May 26, 2026 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 12,500 | n/a |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 16, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| Jun 13, 2025 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 15,000 | n/a |
| Feb 6, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 3,420 | $16.8K |
| Jun 27, 2024 | RENOVARO INC. (RENB) | Grant/Award | 48,137 | n/a |
| Jun 14, 2024 | NOVAVAX INC (NVAX) | Exercise/Conversion | 6,670 | n/a |
| May 21, 2024 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 30,000 | n/a |
| Feb 2, 2024 | RENOVARO BIOSCIENCES INC. (RENB) | Grant/Award | 23,810 | n/a |